Viewing Study NCT03705104



Ignite Creation Date: 2024-05-06 @ 12:12 PM
Last Modification Date: 2024-10-26 @ 12:56 PM
Study NCT ID: NCT03705104
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-03
First Post: 2018-09-20

Brief Title: Living Well With Chronic Pain
Sponsor: Oslo University Hospital
Organization: Oslo University Hospital

Study Overview

Official Title: Living Well With Chronic Pain Using Person-centered E-health Design to Support Self-management
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EPIO
Brief Summary: The goal of this project is to test the effect of an interactive e-health intervention for people with chronic pain
Detailed Description: Chronic pain conditions are common and difficult to cure As much as 30 of adults in Norway experience moderate-to-severe chronic pain ie pain having lasted more than 3 months Chronic pain is also the most common cause of sick leave and disability pension in Norway Despite a clear request from the authorities e-health interventions for chronic pain has not yet been tested and implemented

The aim of this study is to investigate the effect of an interactive e-health intervention for people living with chronic pain using outcome measures such as pain intensity pain acceptance anxietydepression and quality of life

The e-health intervention will first be tested in a pilot study with 50 patients with different pain diagnoses and eventually in a randomized controlled trial with a sample of 240 patients with different pain diagnoses The intervention will consist of one face-to-face introductory group followed by 9 app-based modules containing cognitive behavioral pain self-management material The 9 modules will be distributed over minimum 27 days minimum 3 days per module The participants in the randomized controlled trial will be randomly assigned to use the e-health intervention or to a treatment as usual control group Both groups will receive outcome measures to complete at baseline and at 3 6 and 12 months

Post-RCT the EPIO study will also include a non-randomized group receiving the app-based EPIO program but without receiving an introduction session and follow up phone calls to examine potential benefits from receiving the app-based program only

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None